| Literature DB >> 35924898 |
Karina K Sanchez1, Katia Troha1, Andre Mu1, Samuel E Redford1,2, Justin L McCarville1, Arianna Insenga1, Sarah Stengel1, Yujung Michelle Lee1, Janelle S Ayres1.
Abstract
To combat infections, hosts employ a combination of antagonistic and cooperative defense strategies. The former refers to pathogen killing mediated by resistance mechanisms, while the latter refers to physiological defense mechanisms that promote host health during infection independent of pathogen killing, leading to an apparent cooperation between the host and the pathogen. Previous work has shown that Leptin, a pleiotropic hormone that plays a central role in regulating appetite and energy metabolism, is indispensable for resistance mechanisms, while a role for Leptin signaling in cooperative host-pathogen interactions remains unknown. Using a mouse model of Yersinia pseudotuberculosis (Yptb) infection, an emerging pathogen that causes fever, diarrhea, and mesenteric lymphadenitis in humans, we found that the physiological effects of chronic Leptin-signaling deficiency conferred protection from Yptb infection due to increased host-pathogen cooperation rather than greater resistance defenses. The protection against Yptb infection was independent of differences in food consumption, lipolysis, or fat mass. Instead, we found that the chronic absence of Leptin signaling protects from a shift to lipid utilization during infection that contributes to Yptb lethality. Furthermore, we found that the survival advantage conferred by Leptin deficiency was associated with increased liver and kidney damage. Our work reveals an additional level of complexity for the role of Leptin in infection defense and demonstrates that in some contexts, in addition to tolerating the pathogen, tolerating organ damage is more beneficial for survival than preventing the damage.Entities:
Keywords: Leptin; Yersinia pseudotuberculosis; disease tolerance; host-pathogen cooperation; lipid utilization; physiological damage
Mesh:
Substances:
Year: 2022 PMID: 35924898 PMCID: PMC9476980 DOI: 10.1128/iai.00242-22
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.609